Glory Health Industry Ltd. is actively addressing its financial difficulties by implementing several strategic measures. The company is negotiating the sale of self-owned commercial assets and the overall transfer of projects, including the Shenyang Subsidiary and the Foshan Shengpingli Project, to generate cash. Additionally, the company has applied for the return of land related to the Shenyang and Chongming Island Projects, awaiting government approval which could provide further financial relief. As part of its restructuring efforts, Glory Health has secured a RMB1,314 million borrowing extension from Tianjin Bank and is in ongoing negotiations for loan restructuring and other financing arrangements. These actions aim to resolve significant uncertainties about the company's ability to continue operations. Glory Health plans to complete these restructuring and asset disposal efforts by the second half of 2025 and will continue to provide updates every three months until the situation is resolved.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。